13F filing recap · Q3 2022
What did ArrowMark Partners buy in Q3 2022?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every ArrowMark account, including accounts that belong to no fund below.
Stock value
$8.15B
Positions
328
Estimated turnover
21.0%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
MRTXMirati Therapeutics Inc$31.68Mreported value+453.6K sharesDBRGDigitalbridge Group, Inc.$10.21Mreported value+815.8K sharesVVVValvoline Inc.$8.71Mreported value+343.8K sharesSKINSkinhealth Systems Inc.$8.67Mreported value+735.7K sharesTMDXTransmedics Group, Inc.$8.36Mreported value+200.4K sharesVNOMViper Energy, Inc.$8.24Mreported value+287.4K sharesBLCOBausch & Lomb Corp$7.78Mreported value+507.0K sharesNGMSNeogames S.a.$7.38Mreported value+572.2K sharesMZTIThe Marzetti Company$5.56Mreported value+37.0K sharesHNSTThe Honest Company, Inc.$4.85Mreported value+1.39M sharesBROBrown & Brown, Inc.$4.28Mreported value+70.7K sharesPETSPetmed Express, Inc.$2.75Mreported value+141.0K sharesLYVLive Nation Entertainment, Inc.$2.05Mreported value+27.0K sharesABNBAirbnb, Inc.$1.05Mreported value+10.0K sharesGOOGAlphabet Inc.$625.0Kreported value+6.5K sharesNOWServicenow, Inc.$378.0Kreported value+1.0K sharesBATRALiberty Media Corporation$209.0Kreported value+7.4K sharesPRPermian Resources Corporation$102.0Kreported value+15.0K shares